Sriram Gopal Raju Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 20 Year, 7 Months
- Last Filing with ROC 31 Mar 2019
- Satisfied Charges ₹ 4.00 M
- Revenue Growth -72.63%
- Profit Growth -470.44%
- Ebitda 69.89%
- Net Worth -1.96%
- Total Assets -2.33%
About Sriram Gopal Raju Pharma
Sriram Gopal Raju Pharma Private Limited (SGRPPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 June 2004 and has a history of 20 years and seven months. Its registered office is in Chittoor Dist., Andhra Pradesh.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹4.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Kandalam Rasmith and Subramanyam Kandalam serve as directors at the Company.
Company Details
- LocationChittoor Dist., Andhra Pradesh
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24239AP2004PTC043384
- Company No.
043384
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jun 2004
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Sriram Gopal Raju Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kandalam Rasmith  | Director | 24-Jun-2019 | Current |
| Subramanyam Kandalam | Director | 03-Jun-2004 | Current |
Financial Performance of Sriram Gopal Raju Pharma.
Sriram Gopal Raju Pharma Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 72.63% decrease. The company also saw a substantial fall in profitability, with a 470.44% decrease in profit. The company's net worth dipped by a decrease of 1.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sriram Gopal Raju Pharma?
In 2016, Sriram Gopal Raju Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Saptachala Enterprises Private LimitedKandalam Rasmith is a mutual person
- Vighnaraja Clearing And Forwarding Agencies Private Limited
Kandalam Rasmith is a mutual person
Charges (Loans)
₹0
₹4.00 M
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Nov 2006 | State Bank Of India | ₹2.00 M | Satisfied |
| 31 Mar 2005 | State Bank Of India | ₹2.00 M | Satisfied |
How Many Employees Work at Sriram Gopal Raju Pharma?
Unlock and access historical data on people associated with Sriram Gopal Raju Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sriram Gopal Raju Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sriram Gopal Raju Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
